D-DOPA
From Wikipedia, the free encyclopedia
D-DOPA | |
---|---|
![]() |
|
(R)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid |
|
Identifiers | |
CAS number | 5796-17-8 |
PubChem | 92222 |
ChemSpider | 83260 |
Jmol-3D images | Image 1 |
|
|
|
|
Properties | |
Molecular formula | C9H11NO4 |
Molar mass | 197.19 g mol−1 |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
Infobox references |
D-DOPA (D-3,4-dihydroxyphenylalanine; Dextrodopa) is similar to L-DOPA (Levodopa), but with opposite chirality. Levo- and dextro- rotation reference a molecule's ability to rotate planes of polarized light in either direction. Whereas L-DOPA is moderately effective in the treatment of Parkinson's disease (PD) and dopa-responsive dystonia (DRD), D-DOPA is biologically inactive.
[edit] See also
- L-DOPA (Levodopa; Sinemet, Parcopa, Atamet, Stalevo, Madopar, Prolopa, etc.)
- L-DOPS (Droxidopa)
- Methyldopa (Aldomet, Apo-Methyldopa, Dopamet, Novomedopa, etc.)
- Dopamine (Intropan, Inovan, Revivan, Rivimine, Dopastat, Dynatra, etc.)
- Norepinephrine (Noradrenaline; Levophed, etc.)
- Epinephrine (Adrenaline; Adrenalin, EpiPen, Twinject, etc.)
[edit] References
![]() |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |